Existing cancer drug reduces blood vessel malformations in the brain

Researchers have identified a substance that reduces blood vessel lesions in the brain in the disease cerebral cavernous malformation (CCM). The substance is already used to treat brain tumors in children and could therefore be repurposed relatively rapidly to treat CCM, hopefully replacing surgery, currently the only treatment option.

≈